A clinical trial with DSIP

Eur Neurol. 1984;23(5):386-8. doi: 10.1159/000115717.

Abstract

In an open study 7 patients with severe insomnia were treated by a series of 10 injections with the delta-sleep-inducing peptide (DSIP). In all but 1 case sleep was normalized for follow-up periods of 3-7 months. The mood and performance during the daytime improved as well. A problem may be a long-standing habit of drug addiction.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Clinical Trials as Topic
  • Delta Sleep-Inducing Peptide
  • Female
  • Headache / complications
  • Humans
  • Hypnotics and Sedatives*
  • Lateral Medullary Syndrome / complications
  • Male
  • Middle Aged
  • Oligopeptides / therapeutic use*
  • Polyradiculopathy / complications
  • Sleep Initiation and Maintenance Disorders / drug therapy*
  • Sleep Initiation and Maintenance Disorders / etiology

Substances

  • Hypnotics and Sedatives
  • Oligopeptides
  • Delta Sleep-Inducing Peptide